MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 15.04.2026
Vivos Therapeutics Langfristige Verbindlichkeiten 2011-2026 | VVOS
Langfristige Verbindlichkeiten Jährlich Vivos Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 587 K | 1.4 M | 1.22 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.4 M | 587 K | 1.07 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Bruker Corporation
BRKR
|
1.28 B | $ 39.25 | -0.58 % | $ 5.85 K |  USA |
 |
Align Technology
ALGN
|
184 M | $ 185.94 | -0.32 % | $ 13.9 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 12.5 | -1.23 % | $ 1.69 B | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.61 | 2.33 % | $ 38 M | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.61 | 2.56 % | $ 135 M |  France |
 |
LENSAR
LNSR
|
3.44 M | $ 5.88 | -5.92 % | $ 70.3 M | USA |
 |
Boston Scientific Corporation
BSX
|
11.8 B | $ 63.77 | -1.3 % | $ 94.4 B | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
Eargo
EAR
|
161 M | - | - | $ 10.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 10.64 | 1.72 % | $ 301 M | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
8.87 K | $ 25.35 | -1.4 % | $ 214 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Sintx Technologies
SINT
|
1.76 M | $ 2.69 | -1.82 % | $ 7.46 M | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
Stryker Corporation
SYK
|
13 B | $ 337.01 | -1.24 % | $ 129 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 16.96 | -4.99 % | $ 398 M | USA |
 |
Globus Medical
GMED
|
18.2 M | $ 93.16 | -1.47 % | $ 12.6 B | USA |
 |
Tactile Systems Technology
TCMD
|
14.1 M | $ 25.05 | -1.18 % | $ 573 M | USA |
 |
TELA Bio
TELA
|
30.2 M | $ 0.65 | -0.61 % | $ 30.5 M | USA |
 |
Helius Medical Technologies
HSDT
|
252 K | $ 1.96 | 1.03 % | $ 1.19 M | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Tandem Diabetes Care
TNDM
|
31.7 M | $ 20.25 | -1.98 % | $ 1.38 B | USA |
 |
Inogen
INGN
|
52.5 M | $ 6.33 | 2.1 % | $ 168 M | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.03 | -0.93 % | $ 17.4 M | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
2.52 M | $ 10.85 | -1.27 % | $ 389 M | USA |
 |
Inspire Medical Systems
INSP
|
24.6 M | $ 56.71 | 0.11 % | $ 1.67 B | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 38.23 | -3.07 % | $ 1.19 B | USA |
 |
LivaNova PLC
LIVN
|
516 M | $ 64.7 | -0.68 % | $ 3.53 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
1.02 B | $ 88.42 | 0.55 % | $ 3.07 B | USA |